Anti-IGFBP7 antibody [EPR11912(B)]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(1 Review)
|
(8 Publications)
Rabbit Recombinant Monoclonal IGFBP7 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 8 publications.
View Alternative Names
MAC25, PSF, IGFBP7, Insulin-like growth factor-binding protein 7, IBP-7, IGF-binding protein 7, IGFBP-7, IGFBP-rP1, MAC25 protein, PGI2-stimulating factor, Prostacyclin-stimulating factor, Tumor-derived adhesion factor, TAF
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lung cancer tissue sections labeling IGFBP7 with purified ab171085 at 1 : 250 dilution (2.4 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use). PBS instead of the primary antibody was used as the negative control.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
Immunohistochemical analysis of paraffin-embedded Human pancreas tissue labeling IGFBP7 with ab171085 at 1/50 dilution. This image was produced using unpurified antibody.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
Immunocytochemistry/ Immunofluorescence analysis of MCF7 (human breast adenocarcinoma epithelial cell) cells labeling IGFBP7 with Purified ab171085 at 1 : 100 (6.0 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488 ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
Intracellular flow cytometric analysis of permeabilized 293T cells labeling IGFBP7 with ab171085 at 1/250 dilution (red) compared to a rabbit IgG negative control (green). This image was produced using unpurified antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
Immunofluorescent analysis of MCF7 cells labeling IGFBP7 with ab171085 at 1/250 dilution. This image was produced using unpurified antibody.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling IGFBP7 with purified ab171085 at 1/60 dilution (10 ug/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
Immunohistochemical analysis of paraffin-embedded Human prostate tissue labeling IGFBP7 with ab171085 at 1/50 dilution. This image was produced using unpurified antibody.
- WB
Unknown
Western blot - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
All lanes:
Western blot - Anti-IGFBP7 antibody [EPR11912(B)] (ab171085) at 1/10000 dilution
All lanes:
SW480 (Human colorectal adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
false
- WB
Supplier Data
Western blot - Anti-IGFBP7 antibody [EPR11912(B)] (AB171085)
This image was produced using unpurified antibody.
All lanes:
Western blot - Anti-IGFBP7 antibody [EPR11912(B)] (ab171085) at 1/1000 dilution
Lane 1:
SW480 cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
MCF7 cell lysate at 10 µg
Predicted band size: 29 kDa
false
Related conjugates and formulations (8)
-
578 PE
PE Anti-IGFBP7 antibody [EPR11912(B)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-IGFBP7 antibody [EPR11912(B)]
-
Anti-IGFBP7 antibody [EPR11912(B)] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-IGFBP7 antibody [EPR11912(B)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-IGFBP7 antibody [EPR11912(B)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-IGFBP7 antibody [EPR11912(B)]
-
660 APC
APC Anti-IGFBP7 antibody [EPR11912(B)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-IGFBP7 antibody [EPR11912(B)]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 23:559 PubMed40790215
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 301:110321 PubMed40451432
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37568781
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 4:100934 PubMed36754052
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 24:251 PubMed35761941
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:3701 PubMed32111925
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:682 PubMed31959771
2020
Applications
Unspecified application
Species
Unspecified reactive species
Microarrays (Basel, Switzerland) 5: PubMed27600085
2016
Applications
IHC
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com